HRSA, In Bid To Delay 340B Rule, Says Drug-Price Plan To Span Medicare, Medicaid, 340B

The Health Resources and Services Administration proposed to again delay implementing the 340B ceiling price and penalty rule, and in the process revealed the Trump administration's highly anticipated plan to stem drug costs likely will affect four government health programs: 340B, Medicare Parts B and D, and Medicaid. HRSA says it wouldn't make sense to put the 340B rule into place when a broad HHS drug-cost containment plan will also deal with the program. The agency made the statement Friday...